Robeco Institutional Asset Management
NVAX icon

Robeco Institutional Asset Management’s Novavax NVAX Stock Holding History

Robeco Institutional Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,068
Closed -$521K – 950
2022
Q1 		$521K Hold
7,068
– – ﹤0.01% 772
2021
Q4 		$1.01M Sell
7,068
-1,151
-14% -$198K ﹤0.01% 705
2021
Q3 		$1.71M Buy
8,219
+1,781
+28% +$393K ﹤0.01% 674
2021
Q2 		$1.37M Buy
+6,438
New +$1.18M ﹤0.01% 725

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Robeco Institutional Asset Management's NVAX Position: Q2 2022 in Review

Robeco Institutional Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 7,068 shares — an estimated $521K sold.

Robeco Institutional Asset Management first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $1.71M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Robeco Institutional Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 7,068 Novavax shares in Q2 2022, an estimated $521K.
  • Robeco Institutional Asset Management first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
  • Robeco Institutional Asset Management's Novavax position peaked at $1.71M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.